Disease activity outcomes with different washout periods after switching from natalizumab to an alternative disease-modifying therapy von Hua, Le H., Harris, Haleigh, Conway, Devon, Hersh, Carrie M.

Volltext

Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis population von Conway, Devon S, Hersh, Carrie M, Harris, Haleigh C, Hua, Le H

Volltext

Impact of Switching from Natalizumab to a Moderate versus High Efficacy DMT in Clinical Practice at 24-Month Follow-Up (683) von Hersh, Carrie, Harris, Haleigh, Conway, Devon, Hua, Le

Volltext

Predicting Natalizumab Discontinuation due to Breakthrough Disease in Multiple Sclerosis Patients (P4.2-035) von Conway, Devon, Harris, Haleigh, Hersh, Carrie, Hua, Le

Volltext

Early Impact of Natalizumab Switch to Moderate Versus High Efficacy Disease Modifying Therapy in Clinical Practice (S6.006) von Hersh, Carrie, Harris, Haleigh, Conway, Devon, Hua, Le

Volltext

Efficacy of Short Washout Periods After Switching from Natalizumab to an Alternative DMT. (P3.2-070) von Hua, Le, Harris, Haleigh, Conway, Devon, Hersh, Carrie

Volltext

Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60 von Hua, Le H., Harris, Haleigh, Conway, Devon, Thompson, Nicolas R

Volltext

Effect of switching from natalizumab to moderate- vs high-efficacy DMT in clinical practice von Hersh, Carrie M., Harris, Haleigh, Conway, Devon, Hua, Le H.

Volltext

Discontinuation and Comparative Effectiveness of Dimethyl Fumarate and Fingolimod in Two Large Academic Medical Centers at 36-month Follow-Up (P3.2-065) von Hersh, Carrie, Vollmer, Brandi, Harris, Haleigh, Nair, Kavita, Bermel, Robert, Corboy, John, Fox, Robert, Vollmer, Timothy, Cohen, Jeffrey, Ontaneda, Daniel, Alvarez, Enrique

Volltext

Effect of tobacco use on disease activity and DMT discontinuation inmultiple sclerosis patients treated with dimethyl fumarate orfingolimod von Hersh, Carrie M, Harris Haleigh, Ayers Malissa, Conway, Devon

Volltext

Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up von Vollmer, Brandi, Ontaneda, Daniel, Harris, Haleigh, Nair, Kavita, Bermel, Robert A., Corboy, John R., Fox, Robert J., Vollmer, Timothy, Cohen, Jeffrey A., Alvarez, Enrique, Hersh, Carrie M.

Volltext

Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod von Hersh, Carrie M, Harris, Haleigh, Ayers, Malissa, Conway, Devon

Volltext

Corrigendum to “Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60” [Multiple Sc... von Hua, Le H., Harris, Haleigh, Conway, Devon, Thompson, Nicolas R.

Volltext